Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis

BACKGROUND: The new coronavirus-related pneumonia is causing a global pandemic without specific antiviral drug. Ribavirin has activity against extensive RNA and DNA viruses. We plan to systematically review the use of ribavirin in patients with coronavirus-related pneumonia and meta-analyze the data...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yinhua, Li, Wen, Jiang, Zhiming, Xi, Xiuming, Zhu, Yibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505389/
https://www.ncbi.nlm.nih.gov/pubmed/32957417
http://dx.doi.org/10.1097/MD.0000000000022379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505389/
https://www.ncbi.nlm.nih.gov/pubmed/32957417
http://dx.doi.org/10.1097/MD.0000000000022379

Ejemplares similares